The TGA have announced a raft of changes to listed medicines containing caffeine, including caffeine as a component of a herbal ingredient. NOTE that some of these changes are IMMEDIATE, and some have an 18-month transition period.
All details are included in today's Technical Alert including CMA contact details if you are affected. We are currently communicating with the TGA on number of products expected to be affected by the immediate changes and next steps.
These changes were primarily brought about by Ministerial requests to TGA and FSANZ to protect consumers from accidental caffeine over-consumption, which occurred in response to the caffeine overdose of a young man in Australia (noting that the product consumed was not expected to be a therapeutic good).
